Laura E. Niklason
2021
In 2021, Laura E. Niklason earned a total compensation of $10.8M as President and Chief Executive Officer at Humacyte, a 5,268% increase compared to previous year.
Compensation breakdown
| Bonus | $237,500 |
|---|---|
| Option Awards | $10,021,428 |
| Salary | $500,000 |
| Other | $45,861 |
| Total | $10,804,789 |
Niklason received $10M in option awards, accounting for 93% of the total pay in 2021.
Niklason also received $237.5K in bonus, $500K in salary and $45.9K in other compensation.
Rankings
In 2021, Laura E. Niklason's compensation ranked 919th out of 12,415 executives tracked by ExecPay. In other words, Niklason earned more than 92.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 919 out of 12,415 | 93rd |
Division Manufacturing | 310 out of 5,505 | 94th |
Major group Chemicals And Allied Products | 107 out of 2,375 | 96th |
Industry group Drugs | 90 out of 2,096 | 96th |
Industry Biological Products, Except Diagnostic Substances | 27 out of 449 | 94th |
Source: SEC filing on April 29, 2022.
Niklason's colleagues
We found three more compensation records of executives who worked with Laura E. Niklason at Humacyte in 2021.